Warning letter
Herbal Vitality, Inc.: warning letter of Mar 7, 2023
FDA warning letter 640206 · Division of Human and Animal Food Operations West IV
Key facts
| Reference number | 640206 |
|---|---|
| Company | Herbal Vitality, Inc. |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Mar 7, 2023 |
| Posted date | Mar 21, 2023 |
| Issuing office | Division of Human and Animal Food Operations West IV |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.260(b), 101.36, 111, 111.3, 111.95, 111.260, 101.36(b)(1)(ii), 101.36(e)(1), 101.36(e)(6)(i), 101.4(g), 101.4(h), 101.9(b) and 31 more |
| Inspection city | Sedona |
| Inspection ZIP | 86336 |
| Inspection start date | Jul 11, 2022 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: